Publication | Closed Access

Reversal of apixaban anticoagulation by four‐factor prothrombin complex concentrates in healthy subjects: a randomized three‐period crossover study

ThrombosisHealthy SubjectsCardiovascular DiseaseHematologyApixaban AnticoagulationHemostasisPharmacotherapyCoagulopathyMedicineAnticoagulant